Intuniv is only the second non-stimulant treatment for the condition, following Lilly's off-patent drug Strattera. Perry Sternberg, senior vice president, Neuroscience Business Unit, Shire said ...
The same year, Shire entered into a partnership with Shionogi & Co to co-develop Vyvanse and Intuniv in Japan. "Shire began broadening into rare diseases with the acquisition of orphan drug ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...
But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Read on to find out more ...
The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make available to Medicare recipients for $2 in a pilot program. The program ...
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...
They are available in a generic iteration and under brand names such as Adderall, Ritalin, Concerta, and Focalin. In their immediate-release forms they’re typically effective within an hour ...
Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.
Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...